FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (NYSE American: FOXO) is a post-merger insurtech company that came to market through its business combination with CF Acquisition Corp. VIII, a blank-check vehicle sponsored by Cantor Fitzgerald that completed its IPO in 2021. FOXO applies epigenetic biomarker science to life insurance underwriting and distribution, positioning itself at the intersection of longevity research and consumer insurance products. The company filed its annual 10-K report with the SEC on April 15, 2026, reflecting its continued operations as a publicly traded entity following the merger close in September 2022. Sign up for full data on SpacDesk to access FOXO's complete filing history, sponsor profile, and deal-level analytics alongside hundreds of other SPAC transactions.